Evidence map›Paper›PMID 38909081›Full record

ArticleScientific reports2024

New insights into the anti-inflammatory and anti-melanoma mechanisms of action of azelaic acid and other Fusarium solani metabolites via in vitro and in silico studies.

Mona Ismail, Marwa H A Hassan, Enas I A Mohamed, Ahmed F Azmy, Abeer Moawad, Rabab Mohammed, Mohamed A Zaki

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Metabolites from thePharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mona Ismail *Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.ORCID http://orcid.org/0000-0002-9663-1274
Marwa H A Hassan *Department of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.ORCID http://orcid.org/0000-0002-0952-5984
Enas I A MohamedDepartment of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.ORCID http://orcid.org/0000-0002-6943-9383
Ahmed F AzmyDepartment of Microbiology and Immunology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.ORCID http://orcid.org/0000-0002-7347-9564
Abeer MoawadDepartment of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt. abeermoawad77@gmail.com.ORCID http://orcid.org/0000-0002-0228-6757
Rabab MohammedDepartment of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt. rababmohammed@pharm.bsu.edu.eg.ORCID http://orcid.org/0000-0001-9683-4250
Mohamed A ZakiDepartment of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.ORCID http://orcid.org/0000-0003-4889-8836

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolites exploration of the ethyl acetate extract of Fusarium solani culture broth that was isolated from Euphorbia tirucalli root afforded five compounds; 4-hydroxybenzaldehyde (1), 4-hydroxybenzoic acid (2), tyrosol (3), azelaic acid (4), malic acid (5), and fusaric acid (6). Fungal extract as well as its metabolites were evaluated for their anti-inflammatory and anti-hyperpigmentation potential via in vitro cyclooxygenases and tyrosinase inhibition assays, respectively. Azelaic acid (4) exhibited powerful and selective COX-2 inhibition followed by fusaric acid (6) with IC

Indexed as

Anti-Inflammatory AgentsDicarboxylic AcidsFusariumMolecular Docking SimulationComputer SimulationCyclooxygenase 2Cyclooxygenase InhibitorsFusaric AcidHumansMelanomaMonophenol MonooxygenaseAnti-Inflammatory Agentsazelaic acidCyclooxygenase 2Cyclooxygenase InhibitorsDicarboxylic AcidsFusaric AcidMonophenol MonooxygenaseAzelaicCyclooxygenase (COX-1 and COX-2)DockingEuphorbia tirucalliFusarium solaniMelanomaPirin

Identifiers

PMID38909081
PMCPMC11193793

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.